Article Information
vol. 37 no. 2 273-279
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 23, 2010
- Accepted July 9, 2010
- Published online January 31, 2011.
Article Versions
- previous version (August 6, 2010 - 03:58).
- You are viewing the most recent version of this article.
Copyright & Usage
©ERS 2011
Author Information
- O. Kornmann*,
- R. Dahl#,
- S. Centanni¶,
- A. Dogra+,
- R. Owen§,
- C. Lassen§ and
- B. Kramer+
- on behalf of the INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-μg Doses with COPD Patients) study investigators
- *Pulmonary Division, Internal Medicine, University Hospital, Mainz, Germany
- #Dept of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
- ¶Unità Operativa di Pneumologia, Ospedale S. Paolo, Università degli Studi di Milano, Milan, Italy
- +Respiratory Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- §Novartis Horsham Research Centre, Wimblehurst Road, Horsham, UK
- O. Kornmann, IKF Pneumologie GmbH & Co. KG, Clinical Research Centre Respiratory Diseases, Am Standort IFS, Stresemannallee 3, 60596 Frankfurt, Germany. E-mail: kornmann{at}ikf-pneumologie.de
Article usage
Altmetrics
Vol 37 Issue 2
Table of Contents
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
